Colleen Sweeney

Affiliations: 
Biochemistry and Molecular Biology University of California, Davis, Davis, CA 
Area:
Biochemistry, Molecular Biology
Google:
"Colleen Sweeney"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kado SY, Bein K, Castaneda AR, et al. (2023) Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer. Cells. 12
Sweeney C, Lazennec G, Vogel CFA. (2022) Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer. Frontiers in Pharmacology. 13: 1095289
Umeh-Garcia M, O'Geen H, Simion C, et al. (2022) Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer. British Journal of Cancer
Vogel CFA, Lazennec G, Kado SY, et al. (2021) Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development. Frontiers in Immunology. 12: 625346
Candas-Green D, Xie B, Huang J, et al. (2020) Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nature Communications. 11: 4591
Sweeney C. (2020) Targeting the polyamine pathway-"a means" to overcome chemoresistance in triple-negative breast cancer. The Journal of Biological Chemistry. 295: 6278-6279
Umeh-Garcia M, Simion C, Ho PY, et al. (2019) A Novel Bioengineered MicroRNA-127 Prodrug Suppresses The Growth And Metastatic Potential Of Triple Negative Breast Cancer Cells. Cancer Research
Vogel CFA, Ishihara Y, Campbell CE, et al. (2019) A Protective Role of Aryl Hydrocarbon Receptor Repressor in Inflammation and Tumor Growth. Cancers. 11
Rowson-Hodel AR, Wald JH, Hatakeyama J, et al. (2018) Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer. Oncogene. 37: 197-207
Wald JH, Hatakeyama J, Printsev I, et al. (2017) Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene. 36: 5158-5167
See more...